40 related articles for article (PubMed ID: 24012959)
1. EBP50 phosphorylation by Cdc2/Cyclin B kinase affects actin cytoskeleton reorganization and regulates functions of human breast cancer cell line MDA-MB-231.
Sun C; Zheng J; Cheng S; Feng D; He J
Mol Cells; 2013 Jul; 36(1):47-54. PubMed ID: 23775624
[TBL] [Abstract][Full Text] [Related]
2. NHERF1/EBP50 in Breast Cancer: Clinical Perspectives.
Bellizzi A; Malfettone A; Cardone RA; Mangia A
Breast Care (Basel); 2010; 5(2):86-90. PubMed ID: 21048827
[TBL] [Abstract][Full Text] [Related]
3. Modeling cancer genomic data in yeast reveals selection against ATM function during tumorigenesis.
Hohl M; Mojumdar A; Hailemariam S; Kuryavyi V; Ghisays F; Sorenson K; Chang M; Taylor BS; Patel DJ; Burgers PM; Cobb JA; Petrini JHJ
PLoS Genet; 2020 Mar; 16(3):e1008422. PubMed ID: 32187176
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480.
Gudernova I; Balek L; Varecha M; Kucerova JF; Kunova Bosakova M; Fafilek B; Palusova V; Uldrijan S; Trantirek L; Krejci P
Oncotarget; 2017 Dec; 8(65):109319-109331. PubMed ID: 29312610
[TBL] [Abstract][Full Text] [Related]
5. The molecular sociology of NHERF1 PDZ proteins controlling renal hormone-regulated phosphate transport.
Friedman PA; Mamonova T
Biosci Rep; 2024 Mar; 44(3):. PubMed ID: 38465463
[TBL] [Abstract][Full Text] [Related]
6. NHERF1 Is Required for Localization of PMCA2 and Suppression of Early Involution in the Female Lactating Mammary Gland.
Jeong J; Kim W; Hens J; Dann P; Schedin P; Friedman PA; Wysolmerski JJ
Endocrinology; 2019 Aug; 160(8):1797-1810. PubMed ID: 31087002
[TBL] [Abstract][Full Text] [Related]
7. Na
Zhang X; Liu J; Li Z
Oncol Lett; 2018 May; 15(5):7725-7729. PubMed ID: 29725468
[TBL] [Abstract][Full Text] [Related]
8. NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings.
Centonze M; Saponaro C; Mangia A
Transl Oncol; 2018 Apr; 11(2):374-390. PubMed ID: 29455084
[TBL] [Abstract][Full Text] [Related]
9. Reduced EBP50 expression levels are correlated with unfavorable clinicopathological features of extrahepatic bile duct carcinoma and promote the proliferation and migration of QBC939 cells.
Feng D; Xiong Y; Peng Z; Ma Q; Tao T; Liu H; Liang J; Wei Z; Zheng J; Wang L; Zhang H
Oncol Lett; 2017 Apr; 13(4):2758-2764. PubMed ID: 28454463
[TBL] [Abstract][Full Text] [Related]
10. The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2.
Jeong J; VanHouten JN; Kim W; Dann P; Sullivan C; Choi J; Sneddon WB; Friedman PA; Wysolmerski JJ
J Biol Chem; 2017 Apr; 292(16):6555-6568. PubMed ID: 28235801
[TBL] [Abstract][Full Text] [Related]
11. NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
Tao T; Yang X; Qin Q; Shi W; Wang Q; Yang Y; He J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085111
[TBL] [Abstract][Full Text] [Related]
12. Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance.
Vaquero J; Nguyen Ho-Bouldoires TH; Clapéron A; Fouassier L
Oncogene; 2017 Jun; 36(22):3067-3079. PubMed ID: 28068322
[TBL] [Abstract][Full Text] [Related]
13. Optical sensors to gain mechanistic insights into signaling assemblies.
Tenner B; Mehta S; Zhang J
Curr Opin Struct Biol; 2016 Dec; 41():203-210. PubMed ID: 27611602
[TBL] [Abstract][Full Text] [Related]
14. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S
Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
Cheng S; Li Y; Yang Y; Feng D; Yang L; Ma Q; Zheng S; Meng R; Wang S; Wang S; Jiang WG; He J
FEBS Lett; 2013 Oct; 587(20):3289-95. PubMed ID: 24012959
[TBL] [Abstract][Full Text] [Related]
16. A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling.
DU G; Hao C; Gu Y; Wang Z; Jiang WG; He J; Cheng S
Anticancer Res; 2016 Mar; 36(3):1165-73. PubMed ID: 26977012
[TBL] [Abstract][Full Text] [Related]
17. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
Pan Y; Weinman EJ; Dai JL
Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
